The 21-Gene Recurrence Score Assay for Node-Positive, Early-Stage Breast Cancer and Impact of RxPONDER Trial on Chemotherapy Decision-Making: Have Clinicians Already Decided?
Jasem, Jagar, Fisher, Christine M., Amini, Arya, Shagisultanova, Elena, Rabinovitch, Rachel, Borges, Virginia F., Elias, Anthony, Kabos, PeterVolume:
15
Language:
english
Journal:
Journal of the National Comprehensive Cancer Network
DOI:
10.6004/jnccn.2017.0049
Date:
April, 2017
File:
PDF, 568 KB
english, 2017